This inventor holds 1 USPTO granted patent. Top assignee: Agy Therapeutics, Inc.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Innovative Contributions of Shiming Ye in Gene Function Analysis
Introduction
Shiming Ye is an accomplished inventor based in Albany, California, known for his significant advancements in the field of gene function analysis. With a focus on high-throughput transcriptome studies, Ye has developed methods that enhance our understanding of how genes correlate with cellular activities.
Latest Patents
Shiming Ye holds a patent for the invention titled "High-throughput transcriptome and functional validation analysis." This innovative method focuses on selecting candidate genes correlated with specific cellular states or activities. The patent also outlines a validation process that leverages RNA interference techniques to confirm the role of these genes in establishing cellular states and functions.
Career Highlights
Currently, Shiming Ye is affiliated with Agy Therapeutics, Inc., a company dedicated to advancing therapeutic innovations. His expertise in gene analysis has contributed to the company's efforts in developing effective treatments and enhancing understanding of genetic functions in various cellular contexts.
Collaborations
Throughout his career, Ye has worked alongside notable colleagues such as Thorsten Melcher and Keith McFarland. These collaborations have fostered an environment of shared knowledge and innovation, further propelling advancements in gene function research at Agy Therapeutics, Inc.
Conclusion
Shiming Ye's contributions to the field of gene function analysis have set the stage for future innovations in biotechnology. With his patent and ongoing work at Agy Therapeutics, he continues to play a pivotal role in exploring the complexities of gene functions in relation to cellular activities, paving the way for potential breakthroughs in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile